Trial
NCT06224270
Study of Response to Zoster Vaccine in Adults with Inflammatory Bowel Disease Treated with Medications
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Wisconsin, Madison
Collaborators
GlaxoSmithKline
Condition
Inflammatory Bowel Diseases
Intervention
Adjuvanted Recombinant Zoster Vaccine (RZV)
Why stopped
Funding ended
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-09-25